These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20413572)

  • 1. Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.
    Grabar PB; Rojko S; Logar D; Dolzan V
    Ann Rheum Dis; 2010 May; 69(5):931-2. PubMed ID: 20413572
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
    Kooloos WM; Guchelaar HJ; Huizinga TW; Wessels JA
    Rheumatology (Oxford); 2009 Sep; 48(9):1176-7; author reply 1177. PubMed ID: 19602477
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
    Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
    Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: The pharmacogenetics of methotrexate.
    van der Kooij SM; Wessels JA; Huizinga TW; Guchelaar HJ
    Rheumatology (Oxford); 2008 Apr; 47(4):557; author reply 5557-8. PubMed ID: 18222982
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of methotrexate in the management of rheumatoid arthritis in Dakar. Potential pitfalls.
    Ka MM; Diallo S; Mbengue M; Fary Ka E; Moreira Diop T
    Rev Rhum Engl Ed; 1998 Dec; 65(12):799-800. PubMed ID: 9923052
    [No Abstract]   [Full Text] [Related]  

  • 10. Race and methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P; McLeod H
    J Rheumatol; 2010 May; 37(5):1064; author reply 1065. PubMed ID: 20439524
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cullin1 haplotype variants with rheumatoid arthritis and response to methotrexate.
    Negi S; Kumar A; Thelma BK; Juyal RC
    Pharmacogenet Genomics; 2011 Sep; 21(9):590-3. PubMed ID: 21738080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
    González-Gay MA; Blanco R; García-Porrúa C; Ibáñez D; Vázquez-Caruncho M; Sánchez-Bursón J; Marenco JL
    Arthritis Rheum; 1998 Sep; 41(9):1703-4. PubMed ID: 9751107
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of methotrexate effects and single-nucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al.
    Ranganathan P
    Arthritis Rheum; 2006 Oct; 54(10):3372; author reply 3372-3. PubMed ID: 17009311
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges of predicting treatment response in patients with rheumatoid arthritis.
    Smolen JS; Aletaha D
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):62-3. PubMed ID: 16932630
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.
    Kooloos WM; Wessels JA; van der Kooij SM; Allaart CF; Huizinga TW; Guchelaar HJ
    Ann Rheum Dis; 2009 Aug; 68(8):1371. PubMed ID: 19605746
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.
    Wolf J; Stranzl T; Filipits M; Pohl G; Pirker R; Leeb B; Smolen JS
    Ann Rheum Dis; 2005 Apr; 64(4):564-8. PubMed ID: 15345497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.